Free Trial
NASDAQ:GOVX

GeoVax Labs (GOVX) Stock Price, News & Analysis

GeoVax Labs logo
$0.55 -0.01 (-1.71%)
As of 10/17/2025 04:00 PM Eastern

About GeoVax Labs Stock (NASDAQ:GOVX)

Advanced

Key Stats

Today's Range
$0.54
$0.56
50-Day Range
$0.47
$0.78
52-Week Range
$0.43
$3.88
Volume
548,149 shs
Average Volume
1.28 million shs
Market Capitalization
$16.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Moderate Buy

Company Overview

GeoVax Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

GOVX MarketRank™: 

GeoVax Labs scored higher than 46% of companies evaluated by MarketBeat, and ranked 647th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GeoVax Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    GeoVax Labs has a consensus price target of $8.50, representing about 1,438.5% upside from its current price of $0.55.

  • Amount of Analyst Coverage

    GeoVax Labs has only been the subject of 2 research reports in the past 90 days.

  • Read more about GeoVax Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for GeoVax Labs are expected to grow in the coming year, from ($4.49) to ($1.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GeoVax Labs is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GeoVax Labs is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GeoVax Labs has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about GeoVax Labs' valuation and earnings.
  • Percentage of Shares Shorted

    12.46% of the outstanding shares of GeoVax Labs have been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently decreased by 2.37%, indicating that investor sentiment is improving.
  • Dividend Yield

    GeoVax Labs does not currently pay a dividend.

  • Dividend Growth

    GeoVax Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.46% of the outstanding shares of GeoVax Labs have been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently decreased by 2.37%, indicating that investor sentiment is improving.
  • News Sentiment

    GeoVax Labs has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for GeoVax Labs this week, compared to 2 articles on an average week.
  • Search Interest

    15 people have searched for GOVX on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added GeoVax Labs to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GeoVax Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.20% of the stock of GeoVax Labs is held by insiders.

  • Percentage Held by Institutions

    Only 6.09% of the stock of GeoVax Labs is held by institutions.

  • Read more about GeoVax Labs' insider trading history.
Receive GOVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeoVax Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GOVX Stock News Headlines

FY2025 EPS Estimates for GeoVax Labs Boosted by Roth Capital
An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
See More Headlines

GOVX Stock Analysis - Frequently Asked Questions

GeoVax Labs' stock was trading at $2.47 at the beginning of the year. Since then, GOVX shares have decreased by 77.6% and is now trading at $0.5525.

GeoVax Labs Inc. (NASDAQ:GOVX) issued its quarterly earnings results on Monday, July, 28th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.06. The company earned $0.85 million during the quarter, compared to analyst estimates of $0.37 million. GeoVax Labs had a negative trailing twelve-month return on equity of 408.80% and a negative net margin of 403.88%.
Read the conference call transcript
.

GeoVax Labs shares reverse split on Wednesday, January 31st 2024.The 1-15 reverse split was announced on Wednesday, January 31st 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 31st 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of GOVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GeoVax Labs investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), KALA BIO (KALA), Lipocine (LPCN), Fortress Biotech (FBIO) and Ovid Therapeutics (OVID).

Company Calendar

Last Earnings
7/28/2025
Today
10/18/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOVX
CIK
832489
Employees
10
Year Founded
2001

Price Target and Rating

High Price Target
$9.00
Low Price Target
$8.00
Potential Upside/Downside
+1,438.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.99 million
Net Margins
-403.88%
Pretax Margin
-403.88%
Return on Equity
-408.80%
Return on Assets
-279.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$3.95 million
Price / Sales
4.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.48 per share
Price / Book
1.15

Miscellaneous

Outstanding Shares
29,700,000
Free Float
29,349,000
Market Cap
$16.41 million
Optionable
Not Optionable
Beta
3.31

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:GOVX) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners